Parus Finance (Uk) LTD 10x Genomics, Inc. Transaction History

Parus Finance (Uk) LTD

$345 Million
Q2 2024

A detailed history of Parus Finance (Uk) LTD transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Parus Finance (Uk) LTD holds 12,180 shares of TXG stock, worth $202,188. This represents 0.07% of its overall portfolio holdings.

Number of Shares

12,180

Previous 11,430 6.56%

Holding current value

$202,188

Previous $428,000 44.86%

% of portfolio

0.07%

Previous 0.16%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 16, 2024	BUY	$19.45 - $37.37 $14,587 - $28,027	750 Added 6.56%	12,180 $236,000
Q1 2024 May 15, 2024	SELL	$36.08 - $54.3 $22,008 - $33,123	-610 Reduced 5.07%	11,430 $428,000
Q4 2023 Feb 14, 2024	SELL	$34.32 - $57.55 $21,106 - $35,393	-615 Reduced 4.86%	12,040 $673,000
Q3 2023 Nov 14, 2023	SELL	$40.86 - $62.98 $53,730 - $82,818	-1,315 Reduced 9.41%	12,655 $522,000
Q2 2023 Aug 14, 2023	SELL	$50.96 - $58.72 $7,593 - $8,749	-149 Reduced 1.06%	13,970 $780,000
Q1 2023 May 15, 2023	BUY	$35.33 - $55.79 $13,566 - $21,423	384 Added 2.8%	14,119 $787,000
Q4 2022 Feb 13, 2023	SELL	$24.4 - $41.3 $14,152 - $23,954	-580 Reduced 4.05%	13,735 $500,000
Q3 2022 Nov 14, 2022	BUY	$28.48 - $52.59 $25,802 - $47,646	906 Added 6.76%	14,315 $408,000
Q2 2022 Aug 15, 2022	SELL	$36.95 - $82.41 $1,293 - $2,884	-35 Reduced 0.26%	13,409 $607,000
Q1 2022 May 16, 2022	BUY	$55.7 - $145.79 $344,226 - $900,982	6,180 Added 85.08%	13,444 $1.02 Million
Q4 2021 Feb 14, 2022	BUY	$135.05 - $182.59 $981,003 - $1.33 Million	7,264 New	7,264 $1.08 Million

Others Institutions Holding TXG

# of Institutions

287

Shares Held

94.7M

Call Options Held

162K

Put Options Held

107K

View Full List

About 10x Genomics, Inc.

Ticker TXG
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 95,046,400
Market Cap $1.58B
Description
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...

More about TXG

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parus Finance (Uk) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Parus Finance (Uk) LTD with notifications on news.

Account

Parus Finance (Uk) LTD 10x Genomics, Inc. Transaction History